Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting
Go back to Vera Therapeutics to Present Phase 2a Data on Atacicept in IgA Nephropathy at the American Society of Nephrology Kidney Week 2021 Annual Meeting| Veramark Technologies, Inc. (NASDAQ: VERA) | Delayed: 42.57 -3.96 (8.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.53 | 52 Week High | $1.18 | |||
| Open | $45.92 | 52 Week Low | $0.36 | |||
| Day High | $47.15 | P/E | 709.50 | |||
| Day Low | $42.22 | EPS | $0.06 | |||
| Volume | 1,136,264 | |||||
